This site is intended for healthcare professionals
Doctor holding patient
Supportive care in oncology Learning Zone

Transcript: Why is supportive care critical to cancer management

Last updated:20th May 2024
Published:20th May 2024

Dr Gary Lyman

All transcripts are created from interview footage and directly reflect the content of the interview at the time. The content is that of the speaker and is not adjusted by Medthority.


I cannot emphasise enough how important it is to effectively manage, and ideally prevent chemotherapy-associated adverse events, across the spectrum of modern cancer therapies, both to reduce the risk of a serious life threatening complication, like febrile neutropenia or a pulmonary embolism, as well as to improve compliance with the delivery of effective and potentially curative systemic therapies.
The assessment of risk of patients for these adverse events at baseline and continuously throughout their treatment is critically important and emphasised within the clinical practise guidelines. And, then targeting available and effective interventions, based on that risk assessment, and continually update the the risk of patients, during their treatment and beyond. Adherence to clinical practise guidelines, it needs to be improved. We know that many patients, or clinicians, are not adhering closely to those guidelines, which are evidence-based. And, we need much more research to improve clinical outcomes and quality of life in patients with cancer, to find more safe and effective ways of preventing these important complications of cancer treatment.